SABA Short Volume
Saba Capital Income & Opportunities Fund II (SABA) operates in the Financial Services sector, specifically the Asset Management - Income industry, with a market capitalization near $207.1M, listed on NYSE, carrying a beta of 0.41 to the broader market. Saba Capital Income & Opportunities Fund II is a closed-end investment fund specializing in fixed income, overseen by Saba Capital Management, L. Led by Rupert Harris Johnson Jr., public since 1988-03-17.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-10-14
- Short Volume
- 16.1K
- Total Volume
- 35.3K
- Short %
- 45.44%
- 30-Day Avg Short %
- 25.74%
Showing 30 days of FINRA short volume data for Saba Capital Income & Opportunities Fund II.
Learn how short volume is reported and how to read the data →
Frequently asked SABA short volume questions
- What is the daily SABA short volume?
- As of Oct 14, 2026, Saba Capital Income & Opportunities Fund II (SABA) short volume is 16.1K shares against 35.3K total reported volume, or 45.44% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is SABA short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does SABA short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.